Replies to post #86436 on Innovation Pharmaceuticals Inc (IPIX)

[tduggan]

Karin,

thank you for your report. I hope you add more thoughts and details in the next few days.

You bring great knowledge of the markets in general and bio in particular to this board. Most everyone here acknowledges your contributions.

What I value most is your sense of civility and respect for everyone who comes here. You are an essential part of making this the very best board for the possibly the very best stock.

thank you,

Tom in WA

[TheHound]

Thanks Karin! Any comments as to when the the B-OM trial would start?

[farrell90]

Thanks Karin. Do have any insight as to the mechanism of the anti inflammatory properties of Brilacidin? Cell wall antibiotics are not known for other biologic effects.

Farrell

[Phoenix300]

Great news KarinCA!

[BaartP]

Thank you Karin, enjoy the rest of the event

[Tails]

Many thanks Karin. Super job.
The question you asked Leo re the K trial was dead solid perfect.

Go CTIX!!

[John B]

Thanks Karin for the additional summary and your thoughts. It is great to hear that you have great confidence in your investment here and that you were very impressed with our management team. I appreciate you sharing all this information.

[Vlady 1]

Your recap was excellent and your personal observations and sentiment about the company is exactly what I needed to hear. Thank you for this post !!!

[tombrady12nh]

Thanks you KarinCA!

[cabel]

KarinCA,

I was a bit disappointed that the UofB trial date was not given,... were you able to find out what the holdup there is,...?

Those Europeans,...!

[WILD_4_IPIX]

Thanks very much Karin.....did you happen to ask Leo if you could conduct another interview with him for a SA article ? I personally believe that the timing along with your skills as an interviewer would result in a compelling article about the future potential of Cellceutix.

GO CTIX !

[Pipilongstocking]

Thanks KarinCA.

[crashco]

Thank you Karin, your contributions to this board (and others), are deeply valued.